Cargando…
基于蛋白质组学的肺癌生物标志物研究进展
Proteomic technologies can be applied to cancer research to detect differential protein expression that could find cancer biomakers. Lung cancer biomarker discovery is significant due to its anticipated critical role in early diagnosis, therapy guidance, and prognosis monitoring of lung cancer. Ther...
| Formato: | Online Artículo Texto |
|---|---|
| Lenguaje: | English |
| Publicado: |
中国肺癌杂志编辑部
2015
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5999909/ https://www.ncbi.nlm.nih.gov/pubmed/26104898 http://dx.doi.org/10.3779/j.issn.1009-3419.2015.06.11 |
| _version_ | 1783331551613812736 |
|---|---|
| collection | PubMed |
| description | Proteomic technologies can be applied to cancer research to detect differential protein expression that could find cancer biomakers. Lung cancer biomarker discovery is significant due to its anticipated critical role in early diagnosis, therapy guidance, and prognosis monitoring of lung cancer. Therefore, there is an indeed need to identify new biomarkers for early diagnosis and prognosis that could serve to open novel therapeutic means. This article briefly introduces the latest reports in proteomic studies of lung cancer. It contains diagnostic, prognostic, and predictive biomarkers, and a summary based on the most recent literature and our own work. |
| format | Online Article Text |
| id | pubmed-5999909 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2015 |
| publisher | 中国肺癌杂志编辑部 |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-59999092018-07-06 基于蛋白质组学的肺癌生物标志物研究进展 Zhongguo Fei Ai Za Zhi 综述 Proteomic technologies can be applied to cancer research to detect differential protein expression that could find cancer biomakers. Lung cancer biomarker discovery is significant due to its anticipated critical role in early diagnosis, therapy guidance, and prognosis monitoring of lung cancer. Therefore, there is an indeed need to identify new biomarkers for early diagnosis and prognosis that could serve to open novel therapeutic means. This article briefly introduces the latest reports in proteomic studies of lung cancer. It contains diagnostic, prognostic, and predictive biomarkers, and a summary based on the most recent literature and our own work. 中国肺癌杂志编辑部 2015-06-20 /pmc/articles/PMC5999909/ /pubmed/26104898 http://dx.doi.org/10.3779/j.issn.1009-3419.2015.06.11 Text en 版权所有©《中国肺癌杂志》编辑部2015 https://creativecommons.org/licenses/by/3.0/ This is an open access article distributed in accordance with the terms of the Creative Commons Attribution (CC BY 3.0) License. See: https://creativecommons.org/licenses/by/3.0/ |
| spellingShingle | 综述 基于蛋白质组学的肺癌生物标志物研究进展 |
| title | 基于蛋白质组学的肺癌生物标志物研究进展 |
| title_full | 基于蛋白质组学的肺癌生物标志物研究进展 |
| title_fullStr | 基于蛋白质组学的肺癌生物标志物研究进展 |
| title_full_unstemmed | 基于蛋白质组学的肺癌生物标志物研究进展 |
| title_short | 基于蛋白质组学的肺癌生物标志物研究进展 |
| title_sort | 基于蛋白质组学的肺癌生物标志物研究进展 |
| topic | 综述 |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5999909/ https://www.ncbi.nlm.nih.gov/pubmed/26104898 http://dx.doi.org/10.3779/j.issn.1009-3419.2015.06.11 |
| work_keys_str_mv | AT jīyúdànbáizhìzǔxuédefèiáishēngwùbiāozhìwùyánjiūjìnzhǎn AT jīyúdànbáizhìzǔxuédefèiáishēngwùbiāozhìwùyánjiūjìnzhǎn AT jīyúdànbáizhìzǔxuédefèiáishēngwùbiāozhìwùyánjiūjìnzhǎn |